Supplementary Figures – Turalio Risk Evaluation and Mitigation Strategy for treatment of tenosynovial giant cell tumor: framework and experience

Supplemental Figure 1. Modified FDA framework for benefit-risk counseling to patients about drugs with a REMS* [1]

Supplementary Figure 2. Turalio^® REMS Patient Enrollment Form [2]

Supplementary Figure 3. Turalio^® REMS Prescriber Enrollment Form [3]

Supplementary Figure 4. Turalio^® REMS Liver Adverse Event Reporting Form [4]

Supplemental Figure 5. Turalio^® REMS Pharmacy Enrollment Form [5]

Supplemental Figure 6. Turalio REMS framework